| 1 |
32140785 | Skeletal and mineral metabolic effects of risedronate in a rat model of high-turnover renal osteodystrophy. | 2020 Jul |
2 |
| 2 |
28339837 | Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats. | 2017 Sep 1 |
1 |
| 3 |
25792238 | Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells. | 2016 Mar |
1 |
| 4 |
20431039 | FGF23 fails to inhibit uremic parathyroid glands. | 2010 Jul |
2 |
| 5 |
20739393 | Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH. | 2010 Nov |
3 |
| 6 |
20844473 | Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. | 2010 Nov |
2 |
| 7 |
19339809 | Regulation of fibroblast growth factor 23 production in bone in uremic rats. | 2009 |
2 |
| 8 |
16020653 | 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. | 2005 Dec |
1 |
| 9 |
15040831 | FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. | 2004 Mar |
2 |